1Abdollahi A, Hlatky L, Huber PE. Endostatin: The logic of antiangiogenic therapy. Drug Resist Updat, 2005 , 8 ( 1-2 ) : 59-74.
2O ' Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88(2) : 277-285.
3John H, Preissner KT, Forssmann WG, et al. Novel glycosylated forms of human plasma endostatin arid circulating endostatin-related fragments of collagen ⅩⅤ. Biochemistry, 1999, 38 (32):10217-10224.
4Ferreras M, Felbor U, Lenhard T, et al. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett, 2000, 486(3) : 247 -251.
5Deininger MH, Wybranietz WA, Graepler FT, et al. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J, 2003, 17(10) :1267-1276.
6Sund M, Hamano Y, Sugimoto H, et al. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci, 2005, 102(8): 2934-2939.
7Li Q, Olsen B. R. Increased angiogenic response in aortic explants of collagen ⅩⅤⅢ/endostatin-null mice. Am J Pathol,2004, 165(2): 415-424.
8Isner JM. Cancer and atherosclerosis : the broad mandate of angiogenesis. Circulation, 1999, 99(13) : 1653-1655.
9Ignatescu MC, Gharehbaghi-Schnell E, Hassan A, et al. Expression of the angiogenic protein, platelet-derived endothelial cell growth factor, in coronary atherosclerotic plaques: In vivo correlation of lesional microvessel density and constrictive vascular remodeling. Arterioscler Thromb Vasc Biol, 1999, 19(10): 2340-2347.
10Skovseth DK, Veuger MJ, Sorensen DR, et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood, 2005, 105(3): 1044-1051.
6J F Arenillas,J lvarez-Sab nlvarez-Sab n,Montaner. Angiogenesis in Symptomatic Intracranial Atherosclerosis:Predominance of the Inhibitor Endostatin Is Related to a Greater Extent and Risk of Recurrence[J].Stroke,2005.92-97.
